Typical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features.


Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
04 2020
Historique:
received: 27 12 2019
revised: 17 02 2020
accepted: 23 02 2020
pubmed: 8 3 2020
medline: 27 10 2020
entrez: 8 3 2020
Statut: ppublish

Résumé

We present 783 surgical resections of typical and atypical carcinoid tumors of the lung identified in the pathology files of 20 different pathology departments. All cases were critically reviewed for clinical and pathological features and further correlated with clinical outcomes. Long-term follow-up was obtained in all the patients and statistically analyzed to determine significance of the different parameters evaluated. Of the histopathological features analyzed, the presence of mitotic activity of 4 mitoses or more per 2 mm

Identifiants

pubmed: 32145220
pii: S0046-8177(20)30046-0
doi: 10.1016/j.humpath.2020.02.005
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

98-109

Informations de copyright

Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved.

Auteurs

Cesar A Moran (CA)

Department of Pathology, MD Anderson Cancer Center, Houston, TX, 77030, USA. Electronic address: cesarmoran@mdanderson.org.

Kaleigh E Lindholm (KE)

Department of Pathology, MD Anderson Cancer Center, Houston, TX, 77030, USA.

Hans Brunnström (H)

Lund University, Laboratory Medicine, Department of Clinical Sciences Lund, Pathology, Lund, 22210, Sweden.

Gerald Langman (G)

Heart of England NHS Foundation Trust, Birmingham, B1 1BB, United Kingdom.

Se Jin Jang (SJ)

Asan Medical Center, Ulsan University School of Medicine, Seoul, 100-011, Republic of Korea.

Dominic Spagnolo (D)

PathWest Laboratory Medicine Western Australia, University of Western Australia, School of Pathology and Laboratory Medicine, Nedlands, Western Australia, 6006, Australia; University of Notre Dame, Fremantle, Western Australia, 6006, Australia.

Siaw Ming Chai (SM)

PathWest Laboratory Medicine Western Australia, University of Western Australia, School of Pathology and Laboratory Medicine, Nedlands, Western Australia, 6006, Australia.

Andrew Laycock (A)

PathWest Laboratory Medicine Western Australia, University of Western Australia, School of Pathology and Laboratory Medicine, Nedlands, Western Australia, 6006, Australia; University of Notre Dame, Fremantle, Western Australia, 6006, Australia.

Giovanni Falconieri (G)

General University Hospital, Udine, 33100, Italy.

Stefano Pizzolitto (S)

General University Hospital, Udine, 33100, Italy.

Alessandro de Pellegrin (A)

General University Hospital, Udine, 33100, Italy.

Filomena Medeiros (F)

Essex Cardiothoracic Center, Basildon, CB1 6NU, United Kingdom; Thurrock University Hospitals NHS Foundation Trust, RM16 4XS, United Kingdom.

Lilian Edmunds (L)

Essex Cardiothoracic Center, Basildon, CB1 6NU, United Kingdom; Thurrock University Hospitals NHS Foundation Trust, RM16 4XS, United Kingdom.

Ana Catarino (A)

Hospital da Luz, Lisboa, Portugal.

Fernando Cunha (F)

Portuguese Institute of Oncology, Lisbon, Portugal.

Jae Ro (J)

Methodist Hospital, Houston, TX, 77030, USA.

Sergio Pina-Oviedo (S)

University of Arkansas for Medical Sciences, Little Rock AK, 72701, USA.

Jose Torrealba (J)

UT Southwestern, Dallas, TX, 75390, USA.

Domenico Coppola (D)

Moffitt Cancer Center in Tampa, Florida, 33612, USA.

Fredrik Petersson (F)

National University Hospital, 119260, Singapore.

Ming Lian Oon (ML)

National University Hospital, 119260, Singapore.

Goran Elmberger (G)

Umea University Hospital, Umea, 90130, Sweden.

Santiago Ramon Y Cajal (SR)

Vall D'Hebron University Hospital, Barcelona, 08001, Spain.

Irene Sansano Valero (IS)

Vall D'Hebron University Hospital, Barcelona, 08001, Spain.

Liliana Dalurzo (L)

Hospital Italiano de Buenos Aires, B11675, Argentina.

Fernando Soares (F)

A. C. Camargo Cancer Center, Sao Paulo, 01000-000, Brazil.

Antonio H Campos (AH)

A. C. Camargo Cancer Center, Sao Paulo, 01000-000, Brazil.

Semir Vranic (S)

Qatar University College of Medicine, Qatar.

Faruk Skenderi (F)

University of Sarajevo Clinical Center, 71000, Sarajevo.

Arlene M Correa (AM)

Department of Thoracic Surgery, M D Anderson Cancer Center, Houston, TX, 77030, USA.

Boris Sepesi (B)

Department of Thoracic Surgery, M D Anderson Cancer Center, Houston, TX, 77030, USA.

David Rice (D)

Department of Thoracic Surgery, M D Anderson Cancer Center, Houston, TX, 77030, USA.

Reza Mehran (R)

Department of Thoracic Surgery, M D Anderson Cancer Center, Houston, TX, 77030, USA.

Garrett Walsh (G)

Department of Thoracic Surgery, M D Anderson Cancer Center, Houston, TX, 77030, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH